Synthesis, Aggregation Properties, and Antiprotozoal Activity of Heterocyclic Heterogemini Surfactants 207
31.9, 54.7, 56.5, 57.4, 57.6, 63.4, 125.8, 128.7, 139,7,
142.9.
N-Dodecyl-N-(2-hydroxyethyl)piperidinium Tosy-
Decyl 2-(1-Dodecylpyrrolidinio-1-yl)ethyl Phos-
phate × H2 O (C10PC2N(Pyr)C12). Yield 4.3%; 1H NMR
(CDCl3, TMS) δ: 0.8–0.98 (m, 6H), 1.18–1.52 (m,
32H), 1.57–1.74 (m, 4H), 1.98–2.18 (m, 2H), 2.29–
2.47 (m, 2H), 2.77 (s, 2H), 3.35–3.50 (m, 2H), 3.63–
3.91 (m, 6H), 3.94–4.07 (m, 2H), 4.20–4.31 (m, 2H);
13C NMR (CDCl3, TMS) δ: 14.1, 21.5, 22.7, 23.4, 25.9,
26.5, 29.4, 29.5, 29.6, 29.7, 31.1, 31.9, 58.7, 59.1, 60.2,
63.0, 63.5, 65.6; 31P NMR (CDCl3, H3PO4) δ: 0.26; IR
νmax (cm−1): 3416, 2921, 2851, 1645, 1468, 1260, 1101,
1069, 826.
late (2c). Yield 49.4%; 1H NMR (CDCl3, TMS) δ: 0.88
(t, 3H, J = 6.7 Hz), 1.20–1.32 (m, 18H), 1.58–2.01
(m, 8H), 2.34 (s, 3H), 3.38–3.50 (m, 4H), 3.60–3.76
(m, 2H), 4.03–4.15 (m, 2H), 5.60 (t, 1H, J = 5.8 Hz),
7.14 (d, 2H, J = 7,9 Hz), 7.75 (d, 2H, J = 8.1 Hz);
13C NMR (CDCl3, TMS) δ: 14.3, 20.0, 21.0, 21.5, 21.9,
22.8, 26.6, 29.3, 29.5, 29.6, 29.7, 29.8, 32.1, 55.9, 58.6,
60.1, 61.6, 128.0, 128.8, 139.6, 143.4.
N-Dodecyl-N-(2-hydroxyethyl)morpholinium To-
sylate (2d). Yield 24.2%; H NMR (CDCl3, TMS) δ:
Decyl 2-(1-Dodecylpiperidinio-1-yl)ethyl Phos-
1
1
phate × 1.5H2 O (C10PC2N(Pip)C12). Yield 16.3%; H
0.88 (t, 3H, J = 6.5 Hz), 1.18–1.42 (m, 18H), 1.58–
1.65 (m, 2H), 2.34 (s, 3H), 3.28–3.62 (m, 6H), 3.71–
4.17 (m, 8H), 5.51 (m, 1H), 7.16 (d, 2H, J = 7.8 Hz),
7.18 (d, 2H, J = 7.9 Hz); 13C NMR (CDCl3, TMS) δ:
14.2, 21.3, 21.7, 22.7, 26.3, 29.2, 29.4, 29.5, 29.7, 31.9,
52.7, 55.7, 56.1, 59.0, 59.4, 60.5, 61.1, 63.8, 125.8,
128.9, 139.9, 142.8.
NMR (CDCl3, TMS) δ: 0.81–0.95 (m, 6H), 1.18–1.54
(m, 32H), 1.54–2.05 (m, 10H), 2.91 (s, 3H), 3.44 (m,
4H), 3.75–3.92 (m, 6H), 4.22–4.36 (m, 2H); 13C NMR
(CDCl3, TMS) δ: 14.1, 20.0, 20.8, 21.9, 22.7, 26.0, 26.5,
29.3, 29.4, 29.5, 29.6, 29.7, 31.1, 31.2, 31.9, 57.3, 58.2,
58.3, 59.9, 60.8, 65.4, 65.5; 31P NMR (CDCl3, H3PO4)
δ: 0.78; IR νmax (cm−1): 3417, 2922, 2852, 1634, 1469,
1222, 1100, 1066, 823.
General Procedure for the Preparation of
Decyl 2-(1-Dodecylmorpholinio-1-yl)ethyl Phos-
phate × 1.5H2 O (C10PC2N(Morph)C12). Yield 1.7%;
1H NMR (CDCl3, TMS) δ: 0.84–0.96 (m, 6H), 1.18–
1.45 (m, 32H), 1.54–1.65 (m, 2H), 1.65 (m, 2H),
2.70 (s, 3H), 3.46–3.69 (m, 4H), 3.76–3.86 (m, 2H),
3.90–4.11 (m, 6H), 4.13–4.25 (m, 2H), 4.25–4.36 (m,
2H); 13C NMR (CDCl3, TMS) δ: 14.1, 21.9, 22.7, 25.9,
26.5, 29.3, 29.4, 29.5, 29.6, 29.7, 31.0, 31.1, 31.9, 58.3,
58.4, 59.1, 60.0, 60.1, 60.6, 65.6; 31P NMR (CDCl3,
H3PO4) δ: 0.15; IR νmax (cm−1): 3420, 2922, 2852,
1636, 1468, 1249, 1087, 827.
Alkylphosphocholines. Solution
of
decanol
(9 mmol) in chloroform (20 mL) was added
dropwise at 0◦C to a stirred solution of phosphorous
oxychloride (10 mmol) and triethylamine (20 mmol)
in chloroform (10 mL). The resulting mixture was
stirred at room temperature (r.t.) for 2 h. This
intermediate was used immediately without any
purification. Pyridine (15 mL) was added dropwise
at t = 0◦C to the resulting solution, followed by the
addition of choline tosylate analogue (12.5 mmol).
The reaction mixture was stirred at r.t. overnight.
After cooling, the mixture was hydrolyzed by ad-
dition of H2O (1.5 mL) and stirred for 1 h at r.t.
The solvents were evaporated in vacuum, and the
resulting crude solid was dissolved in a mixture
of tetrahydrofuran–water (5:1 V/V). To the stirred
solution, exchange resin MB3 was added sequen-
tially until the color of the resin ceased to change.
Then, the resin was filtered off and the solvents were
evaporated in vacuum. The resulting crude solid
was purified by crystallization from a mixture of
chloroform and acetone or chloroform and diethyl
ether. ALPs were dried in vacuo over P4O10.
Testing Heterogemini Surfactants for
Trophocidal Susceptibility
These procedures were carried out using the mod-
ified methods described by Walochnik et al. [29].
The cultures of amoeba were grown axenically in
100-mL Erlenmeyer flasks. Axenic culture was ob-
tained from the monoxenic culture of clinically iso-
lated Acanthamoeba lugdunensis as reported previ-
ously [40]. Trophozoites were harvested from 2-day
monoxenic plate cultures and transferred to Bacto-
Casitone/Serum (BCS) medium with penicillin and
ampicillin. Actively growing trophozoites were har-
vested by centrifugation at 500×g for 7 min, and
subsequently they were incubated at 37◦C for 3
days. Thereafter, trophozoites were transferred to
BCS medium without antibiotics and cultivated at
37◦C for 3 days. The cultivation in the BCS medium
was repeated five times, then the trophozoites were
transferred to peptone–yeast extract–glucose (PYG)
medium and afterwards cultivated in this medium.
Experiments were carried out in 96-well microtiter
Decyl 2-[Dodecyl(dimethyl)ammonio]ethyl Phos-
1
phate × H O (C10PC2NC12). Yield 22.2%; H NMR
2
(CDCl3, TMS) δ: 0.84–0.92 (m, 6H), 1.18–1.41 (m,
32H), 1.55–1.78 (m, 4H), 2.18 (s, 2H), 3.35 (s, 6H),
3.41–3.50 (m, 2H), 3.76–3.89 (m, 4H), 4.27–4.35 (m,
2H); 13C NMR (CDCl3, TMS) δ: 14.1, 22.7, 22.9, 26.0,
26.3, 29.3, 29.4, 29.5, 29.6, 29.7, 31.0, 31.1, 31.9, 51.9,
58.8, 64.2, 65.5, 65.6, 65.9; 31P NMR (CDCl3, H3PO4)
δ: 0.76; IR νmax (cm−1): 3427, 2919, 2851, 1635, 1469,
1242, 1100, 1067, 822.
Heteroatom Chemistry DOI 10.1002/hc